DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Quinn MA, Conaghan PG, O’Connor PJ. et al.
Very early treatment
with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid
arthritis reduces magnetic resonance imaging evidence of synovitis
and damage, with sustained benefit after infliximab withdrawal:
results from a twelve-month randomized, double-blind, placebo-controlled
trial.
Arthritis Rheum 2005; 52: 27-35
We do not assume any responsibility for the contents of the web pages of other providers.